Skip to main content
. Author manuscript; available in PMC: 2019 Mar 15.
Published in final edited form as: Diabetes Obes Metab. 2010 Nov;12(11):994–1003. doi: 10.1111/j.1463-1326.2010.01290.x

Table 4.

Plasma FFA dynamics during the FSIVGTT.

Pre-Tx 12 months post-Tx NDC p (pre-Tx to NDC) p (pre- vs. post-Tx)
Baseline (μmol/l) 424 ± 104 245 ± 48 391 ± 64 0.85 0.13
Nadir (μmol/l) 131 ± 37 62 ± 14 102 ± 40 0.66 0.08
AUC insulin phase 1 (pmol/l-min) 25 ± 61 637 ± 251 1418 ± 235 0.0001 0.06
Mean FFA phase 1 (μmol/l) 505 ± 125 333 ± 48 410 ± 104 0.66 0.20
Mean FFA 0–20 min (μmol/l) 500 ± 120 303 ± 42 364 ± 98 0.51 0.13
Fractional disposal rate (%)/min(10–40) −2.5 ± 0.9 −3.2 ± 1.6 −1.8 ± 2.3 0.73 0.70
Fractional disposal rate (%)/min(10–20) −0.9 ± 0.7 −5.3 ± 2.7 −6.9 ± 1.6 0.0007 0.06
Fractional disposal rate (%)/min(20–40) −5.2 ± 1.8 −3.9 ± 2.3 0.1 ± 2.0 0.12 0.67
AUC insulin phase 2 (pmol/l·min) 22 530 ± 5442 11 056 ± 1808 13 162 ± 3742 0.32 0.05
Fractional disposal rate (%)/min(10–70) −1.9 ± 0.4 −1.4 ± 0.2 −1.0 ± 0.5 0.26 .033
Mean FFA phase 3 (μmol/l·min) 348 ± 43 288 ± 34 335 ± 13 0.85 0.29

AUC, area under the curve; FFA, free fatty acid; Tx, transplant.